As such, higher positive rates of all six detected autoantibodies were observed in cured leprosy patients: 91 (46.0%), 30 (15.2%), 74 (37.4%), 55 (27.8%), 95 (48.0%), and 26 (13.1%) patients were positive for ACA, ENA, ASO, ANA, RF, and dsDNA, respectively; while the positive rate of these autoantibodies ranges around 3–5% in normal controls. This evidence concerns the gene BTG3 and leprosy.